JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy

By Yahoo! Finance   |   4 weeks ago
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy

Wolfgang Wienand, CEO of Lonza, shared plans to exit the Capsules and Health Ingredients business at the JP Morgan Annual Healthcare Conference. Despite concerns, Wienand is confident in finding a valuable solution for shareholders.

Read More

Did you find this insightful?